Regeneron Pharmaceuticals (REGN) had the highest return in 2012 by a large-cap US stock or large-cap US stock in the Nasdaq Composite (IXIC), returning 202.7%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Regeneron Pharmaceuticals (REGN) | 2012 | 202.72% |
IES (IESC) | 2012 | 146.63% |
Alnylam Pharmaceuticals (ALNY) | 2012 | 119.09% |
Insmed (INSM) | 2012 | 114.42% |
Genmab A-S (GMAB) | 2012 | 114.07% |
Expedia (EXPE) | 2012 | 110.3% |
Seagate Technology (STX) | 2012 | 90.7% |
Madrigal Pharmaceuticals (MDGL) | 2012 | 89.1% |
Illumina (ILMN) | 2012 | 79.32% |
Gilead Sciences (GILD) | 2012 | 77.16% |
Axon Enterprise (AXON) | 2012 | 70.61% |
NXP Semiconductors (NXPI) | 2012 | 66.79% |
eBay (EBAY) | 2012 | 65.42% |
Lululemon Athletica (LULU) | 2012 | 60.48% |
ICON (ICLR) | 2012 | 60.09% |
Comcast (CMCSA) | 2012 | 56.93% |
Nordson (NDSN) | 2012 | 51.25% |
Warner Bros Discovery (WBD) | 2012 | 51.25% |
Monolithic Power Systems (MPWR) | 2012 | 50.99% |
Ulta Beauty (ULTA) | 2012 | 50.77% |
Popular (BPOP) | 2012 | 47.45% |
Manhattan Associates (MANH) | 2012 | 46.28% |
DexCom (DXCM) | 2012 | 42.75% |
Biomarin Pharmaceutical (BMRN) | 2012 | 42.69% |
Amazon (AMZN) | 2012 | 42.63% |
Large-cap stocks are treated as having a market cap of $10B+.